Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Ensituximab [USAN:INN]
RN: 1092658-06-4
UNII: F988K568V2

Note

  • Targets an MUC5AC variant for treatment of refractory pancreatic and colorectal cancer.

Molecular Formula

  • C6342-H9800-N1678-O1985-S46
 

Classification Code

  • Treatment of Cancer
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Ensituximab [USAN:INN]

Synonyms

  • Ensituximab
  • Immunoglobulin G1, anti-(human mucin-5AC (tracheobronchial mucin, gastric mucin, Lewis B blood group antigen), colorectal and pancreatic carcinoma-associated antigen); human-mouse chimeric monoclonal NPC-1C gamma1 heavy chain (216-213')- disulfide with human-mouse chimeric monoclonal NPC-1C kappa light chain dimer (222- 222'':225-225'')-bisdisulfide
  • NPC-1C
  • UNII-F988K568V2

Systematic Name

  • Immunoglobulin G1, anti-(colorectal and pancreatic carcinoma-associated antigen) (human-mouse monoclonal NPC-1C heavy chain), disulfide with human-mouse monoclonal NPC-1C kappa-chain, dimer

Registry Numbers

CAS Registry Number

  • 1092658-06-4

FDA UNII

  • F988K568V2

System Generated Number

  • 1092658064